Skip to main content
NCBI home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1991 Sep 1;145(5):413–428.

Periodic health examination, 1991 update: 3. Secondary prevention of prostate cancer. Canadian Task Force on the Periodic Health Examination.

PMCID: PMC1335825  PMID: 1878824

Full text

PDF
413

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andriole G. L., Kavoussi L. R., Torrence R. J., Lepor H., Catalona W. J. Transrectal ultrasonography in the diagnosis and staging of carcinoma of the prostate. J Urol. 1988 Oct;140(4):758–760. doi: 10.1016/s0022-5347(17)41805-2. [DOI] [PubMed] [Google Scholar]
  2. Aro J. L., Haapiainen R. K., Rannikko S. A., Alfthan O. S. High dose polyoestradiol phosphate with and without acetosalicylic acid versus orchiectomy in the treatment of prostatic cancer. Finnprostate Group. Br J Urol. 1989 May;63(5):512–514. doi: 10.1111/j.1464-410x.1989.tb05946.x. [DOI] [PubMed] [Google Scholar]
  3. Aro J., Haapiainen R., Kajanti M., Rannikko S., Alfthan O. Comparison of endocrine and radiation therapy in locally advanced prostatic cancer. Eur Urol. 1988;15(3-4):182–186. doi: 10.1159/000473429. [DOI] [PubMed] [Google Scholar]
  4. Asbell S. O., Krall J. M., Pilepich M. V., Baerwald H., Sause W. T., Hanks G. E., Perez C. A. Elective pelvic irradiation in stage A2, B carcinoma of the prostate: analysis of RTOG 77-06. Int J Radiat Oncol Biol Phys. 1988 Dec;15(6):1307–1316. doi: 10.1016/0360-3016(88)90225-8. [DOI] [PubMed] [Google Scholar]
  5. Asbell S. O., Martz K. L., Pilepich M. V., Baerwald H. H., Sause W. T., Doggett R. L., Perez C. A. Impact of surgical staging in evaluating the radiotherapeutic outcome in RTOG phase III study for A2 and B prostate carcinoma. Int J Radiat Oncol Biol Phys. 1989 Nov;17(5):945–951. doi: 10.1016/0360-3016(89)90140-5. [DOI] [PubMed] [Google Scholar]
  6. Babaian R. J., Lamki L. M. Radioimmunoscintigraphy of prostate cancer. Semin Nucl Med. 1989 Oct;19(4):309–321. doi: 10.1016/s0001-2998(89)80023-6. [DOI] [PubMed] [Google Scholar]
  7. Badalament R. A., Drago J. R. Prostate cancer. Promising advances that may alter survival rates. Postgrad Med. 1990 Apr;87(5):65-7, 70-2. doi: 10.1080/00325481.1990.11704627. [DOI] [PubMed] [Google Scholar]
  8. Beisland H. O. Neodymium-YAG laser in the treatment of localized prostatic cancer. Acta Urol Belg. 1989;57(3):709–713. [PubMed] [Google Scholar]
  9. Bostwick D. G. The pathology of early prostate cancer. CA Cancer J Clin. 1989 Nov-Dec;39(6):376–393. doi: 10.3322/canjclin.39.6.376. [DOI] [PubMed] [Google Scholar]
  10. Boxer R. J., Kaufman J. J., Goodwin W. E. Radical prostatectomy for carcinoma of the prostate: 1951-1976. A review of 329 patients. J Urol. 1977 Feb;117(2):208–213. doi: 10.1016/s0022-5347(17)58402-5. [DOI] [PubMed] [Google Scholar]
  11. Braeckman J., Corujeira-Figueira F., Goossens A., Keuppens F. Ultrasonically guided prostatic biopsy: technical improvements. Eur Urol. 1990;17(3):203–205. doi: 10.1159/000464038. [DOI] [PubMed] [Google Scholar]
  12. Brawer M. K., Lange P. H. Prostate-specific antigen in management of prostatic carcinoma. Urology. 1989 May;33(5 Suppl):11–16. doi: 10.1016/0090-4295(89)90100-3. [DOI] [PubMed] [Google Scholar]
  13. Brenner D. W., Ladaga L. E., Fillion M. B., Schlossberg S. M., Schellhammer P. F. Comparison of transrectal fine-needle aspiration cytology and core needle biopsy in diagnosis of prostate cancer. Urology. 1990 May;35(5):381–384. doi: 10.1016/0090-4295(90)80076-y. [DOI] [PubMed] [Google Scholar]
  14. Brooman P. J., Peeling W. B., Griffiths G. J., Roberts E., Evans K. A comparison between digital examination and per-rectal ultrasound in the evaluation of the prostate. Br J Urol. 1981 Dec;53(6):617–620. doi: 10.1111/j.1464-410x.1981.tb03274.x. [DOI] [PubMed] [Google Scholar]
  15. Byar D. P., Corle D. K. VACURG randomised trial of radical prostatectomy for stages I and II prostatic cancer. Veterans Administration Cooperative Urological Research Group. Urology. 1981 Apr;17(4 Suppl):7–11. [PubMed] [Google Scholar]
  16. Byar D. P. Incidence, mortality, and survival statistics for prostatic cancer. Prog Clin Biol Res. 1987;239:785–796. [PubMed] [Google Scholar]
  17. Byar D. P. Survival of patients with incidentally found microscopic cancer of the prostate: results of a clinical trial of conservative treatment. J Urol. 1972 Dec;108(6):908–913. doi: 10.1016/s0022-5347(17)60904-2. [DOI] [PubMed] [Google Scholar]
  18. Cantrell B. B., DeKlerk D. P., Eggleston J. C., Boitnott J. K., Walsh P. C. Pathological factors that influence prognosis in stage A prostatic cancer: the influence of extent versus grade. J Urol. 1981 Apr;125(4):516–520. doi: 10.1016/s0022-5347(17)55092-2. [DOI] [PubMed] [Google Scholar]
  19. Carlton C. E., Jr, Scardino P. T. Combined interstitial and external irradiation for prostatic cancer. Prog Clin Biol Res. 1987;243B:141–169. [PubMed] [Google Scholar]
  20. Carter B. S., Carter H. B., Isaacs J. T. Epidemiologic evidence regarding predisposing factors to prostate cancer. Prostate. 1990;16(3):187–197. doi: 10.1002/pros.2990160302. [DOI] [PubMed] [Google Scholar]
  21. Carter H. B., Riehle R. A., Jr, Koizumi J. H., Amberson J., Vaughan E. D., Jr Fine needle aspiration of the abnormal prostate: a cytohistological correlation. J Urol. 1986 Feb;135(2):294–298. doi: 10.1016/s0022-5347(17)45618-7. [DOI] [PubMed] [Google Scholar]
  22. Carter S. S., Torp-Pedersen S. T., Holm H. H. Ultrasound-guided implantation techniques in treatment of prostate cancer. Urol Clin North Am. 1989 Nov;16(4):751–762. [PubMed] [Google Scholar]
  23. Chang P., Friedland G. W. The role of imaging in screening for prostate cancer. A decision analysis perspective. Invest Radiol. 1990 May;25(5):591–595. doi: 10.1097/00004424-199005000-00021. [DOI] [PubMed] [Google Scholar]
  24. Charig C. R., Rundle J. S. Flushing. Long-term side effect of orchiectomy in treatment of prostatic carcinoma. Urology. 1989 Mar;33(3):175–178. doi: 10.1016/0090-4295(89)90385-3. [DOI] [PubMed] [Google Scholar]
  25. Chodak G. W., Keller P., Schoenberg H. W. Assessment of screening for prostate cancer using the digital rectal examination. J Urol. 1989 May;141(5):1136–1138. doi: 10.1016/s0022-5347(17)41192-x. [DOI] [PubMed] [Google Scholar]
  26. Chodak G. W., Keller P., Schoenberg H. Routine screening for prostate cancer using the digital rectal examination. Prog Clin Biol Res. 1988;269:87–98. [PubMed] [Google Scholar]
  27. Chodak G. W., Neumann J., Blix G., Sutton H., Farah R. Effect of external beam radiation therapy on serum prostate-specific antigen. Urology. 1990 Apr;35(4):288–294. doi: 10.1016/0090-4295(90)80147-f. [DOI] [PubMed] [Google Scholar]
  28. Chodak G. W., Steinberg G. D., Bibbo M., Wied G., Straus F. S., 2nd, Vogelzang N. J., Schoenberg H. W. The role of transrectal aspiration biopsy in the diagnosis of prostatic cancer. J Urol. 1986 Feb;135(2):299–302. doi: 10.1016/s0022-5347(17)45619-9. [DOI] [PubMed] [Google Scholar]
  29. Chodak G. W. Transrectal ultrasonography: is it ready for routine use? JAMA. 1988 May 13;259(18):2744–2745. [PubMed] [Google Scholar]
  30. Chodak G. W., Wald V., Parmer E., Watanabe H., Ohe H., Saitoh M. Comparison of digital examination and transrectal ultrasonography for the diagnosis of prostatic cancer. J Urol. 1986 May;135(5):951–954. doi: 10.1016/s0022-5347(17)45935-0. [DOI] [PubMed] [Google Scholar]
  31. Clements R., Griffiths G. J., Peeling W. B., Roberts E. E., Evans K. T. How accurate is the index finger? A comparison of digital and ultrasound examination of the prostatic nodule. Clin Radiol. 1988 Jan;39(1):87–89. doi: 10.1016/s0009-9260(88)80352-0. [DOI] [PubMed] [Google Scholar]
  32. Cooner W. H., Mosley B. R., Rutherford C. L., Jr, Beard J. H., Pond H. S., Terry W. J., Igel T. C., Kidd D. D. Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J Urol. 1990 Jun;143(6):1146–1154. doi: 10.1016/s0022-5347(17)40211-4. [DOI] [PubMed] [Google Scholar]
  33. Crawford E. D. Combined androgen blockade. Urology. 1989 Oct;34(4 Suppl):22–56. doi: 10.1016/0090-4295(89)90231-8. [DOI] [PubMed] [Google Scholar]
  34. Davies A. H., Davis H. L., Ramarakha P., Durrant K. D., Fellows G. J. External-beam radiation for carcinoma of the prostate. Eur Urol. 1990;18(2):117–119. doi: 10.1159/000463886. [DOI] [PubMed] [Google Scholar]
  35. Devonec M., Fendler J. P., Monsallier M., Mouriquand P., Mestas J. L., Dutrieux-Berger N., Perrin P. Prostatic cancer diagnosis with ultrasonically guided prostatic biopsy: results in 226 cases. Prog Clin Biol Res. 1989;303:35–40. [PubMed] [Google Scholar]
  36. Donn A. S., Muir C. S. Prostatic cancer: some epidemiological features. Bull Cancer. 1985;72(5):381–390. [PubMed] [Google Scholar]
  37. Drago J. R., Badalament R. A., Nesbitt J. A., Geraniotis E., Horchak A. Localized staging of prostate carcinoma: comparison of transrectal ultrasound and magnetic resonance imaging. Urology. 1990 Jun;35(6):511–512. doi: 10.1016/0090-4295(90)80105-v. [DOI] [PubMed] [Google Scholar]
  38. Drago J. R., Badalament R. A., Nesbitt J. A. Radical prostatectomy 1972-1987 single institutional experience: comparison of standard radical prostatectomy and nerve-sparing technique. Urology. 1990 May;35(5):377–380. doi: 10.1016/0090-4295(90)80075-x. [DOI] [PubMed] [Google Scholar]
  39. Drago J. R., Badalament R. A., Wientjes M. G., Smith J. J., Nesbitt J. A., York J. P., Ashton J. J., Neff J. C. Relative value of prostate-specific antigen and prostatic acid phosphatase in diagnosis and management of adenocarcinoma of prostate. Ohio State University experience. Urology. 1989 Oct;34(4):187–192. doi: 10.1016/0090-4295(89)90369-5. [DOI] [PubMed] [Google Scholar]
  40. Drago J. R. The role of new modalities in the early detection and diagnosis of prostate cancer. CA Cancer J Clin. 1989 Nov-Dec;39(6):326–336. doi: 10.3322/canjclin.39.6.326. [DOI] [PubMed] [Google Scholar]
  41. Dähnert W. F., Hamper U. M., Eggleston J. C., Walsh P. C., Sanders R. C. Prostatic evaluation by transrectal sonography with histopathologic correlation: the echopenic appearance of early carcinoma. Radiology. 1986 Jan;158(1):97–102. doi: 10.1148/radiology.158.1.3510032. [DOI] [PubMed] [Google Scholar]
  42. Elder J. S., Jewett H. J., Walsh P. C. Radical perineal prostatectomy for clinical stage B2 carcinoma of the prostate. J Urol. 1982 Apr;127(4):704–706. doi: 10.1016/s0022-5347(17)54005-7. [DOI] [PubMed] [Google Scholar]
  43. Epstein J. I., Paull G., Eggleston J. C., Walsh P. C. Prognosis of untreated stage A1 prostatic carcinoma: a study of 94 cases with extended followup. J Urol. 1986 Oct;136(4):837–839. doi: 10.1016/s0022-5347(17)45097-x. [DOI] [PubMed] [Google Scholar]
  44. Fosså S. D., Aaronson N., Calais da Silva F., Denis L., Newling D., Hosbach G., Kaalhus O. Quality of life in patients with muscle-infiltrating bladder cancer and hormone-resistant prostatic cancer. Eur Urol. 1989;16(5):335–339. doi: 10.1159/000471611. [DOI] [PubMed] [Google Scholar]
  45. Foti A. G., Cooper J. F., Herschman H., Malvaez R. R. Detection of prostatic cancer by solid-phase radioimmunoassay of serum prostatic acid phosphatase. N Engl J Med. 1977 Dec 22;297(25):1357–1361. doi: 10.1056/NEJM197712222972501. [DOI] [PubMed] [Google Scholar]
  46. Fritzsche P. J., Axford P. D., Ching V. C., Rosenquist R. W., Moore R. J. Correlation of transrectal sonographic findings in patients with suspected and unsuspected prostatic disease. J Urol. 1983 Aug;130(2):272–274. doi: 10.1016/s0022-5347(17)51103-9. [DOI] [PubMed] [Google Scholar]
  47. Fujiwara K., Isaka S., Shimazaki J. [Magnetic resonance imaging in the diagnosis of prostatic carcinoma and benign hyperplasia]. Nihon Hinyokika Gakkai Zasshi. 1989 Sep;80(9):1336–1342. doi: 10.5980/jpnjurol1989.80.1336. [DOI] [PubMed] [Google Scholar]
  48. Gibbons R. P. Management of stage A-2 prostate cancer. Prog Clin Biol Res. 1987;243B:333–338. [PubMed] [Google Scholar]
  49. Gilbertsen V. A. Cancer of the prostate gland. Results of early diagnosis and therapy undertaken for cure of the disease. JAMA. 1971 Jan 4;215(1):81–84. doi: 10.1001/jama.215.1.81. [DOI] [PubMed] [Google Scholar]
  50. Gluck R., Cohen M., Warner R. Transrectal ultrasound in early detection of clinical stage A prostate cancer. Urology. 1989 Jul;34(1):58–61. doi: 10.1016/0090-4295(89)90161-1. [DOI] [PubMed] [Google Scholar]
  51. Goldenberg S. L., Ajzen S. A., Allen G. J., Cooperberg P. L., Perler Z., Chan N. H. Combined biopsy techniques: an approach to the diagnosis of prostatic malignancy. J Urol. 1989 Apr;141(4):870–872. doi: 10.1016/s0022-5347(17)41036-6. [DOI] [PubMed] [Google Scholar]
  52. Green N., Treible D., Wallack H. Prostate cancer: post-irradiation incontinence. J Urol. 1990 Aug;144(2 Pt 1):307–309. doi: 10.1016/s0022-5347(17)39438-7. [DOI] [PubMed] [Google Scholar]
  53. Griffiths G. J., Clements R., Peeling W. B. The current status of transrectal ultrasonography in the diagnosis and management of prostatic cancer. Clin Radiol. 1989 Jul;40(4):337–340. doi: 10.1016/s0009-9260(89)80113-8. [DOI] [PubMed] [Google Scholar]
  54. Grups J. W., Gruss A., Wirth M., Frohmüller H. G. Diagnostic value of transrectal ultrasound in tumor staging and in the detection of incidental prostatic cancer. Urol Int. 1990;45(1):38–40. doi: 10.1159/000281656. [DOI] [PubMed] [Google Scholar]
  55. Guinan P., Bhatti R., Ray P. An evaluation of prostate specific antigen in prostatic cancer. J Urol. 1987 Apr;137(4):686–689. doi: 10.1016/s0022-5347(17)44175-9. [DOI] [PubMed] [Google Scholar]
  56. Guinan P., Bush I., Ray V., Vieth R., Rao R., Bhatti R. The accuracy of the rectal examination in the diagnosis of prostate carcinoma. N Engl J Med. 1980 Aug 28;303(9):499–503. doi: 10.1056/NEJM198008283030906. [DOI] [PubMed] [Google Scholar]
  57. Guinan P., Ray P., Bhatti R., Rubenstein M. An evaluation of five tests to diagnose prostate cancer. Prog Clin Biol Res. 1987;243A:551–558. [PubMed] [Google Scholar]
  58. Haddad F. S. Re: Risk factors for perineal seeding of prostate cancer after needle biopsy. J Urol. 1990 Mar;143(3):587–588. doi: 10.1016/s0022-5347(17)40032-2. [DOI] [PubMed] [Google Scholar]
  59. Hanks G. E. External beam radiation therapy for prostate cancer clinically confined to the gland. Urology. 1989 May;33(5 Suppl):21–26. doi: 10.1016/0090-4295(89)90102-7. [DOI] [PubMed] [Google Scholar]
  60. Hedlund P. O., Gustafson H., Sjögren S. Cardiovascular complications to treatment of prostate cancer with estramustine phosphate (Estracyt) or conventional estrogen. A follow-up of 212 randomized patients. Scand J Urol Nephrol Suppl. 1980;55:103–105. [PubMed] [Google Scholar]
  61. Henriksson P., Linde B., Edhag O. Deleterious effects of low-dose oestrogen therapy on coronary status in patients with prostatic cancer. Eur Heart J. 1987 Jul;8(7):779–784. doi: 10.1093/eurheartj/8.7.779. [DOI] [PubMed] [Google Scholar]
  62. Hodge K. K., McNeal J. E., Stamey T. A. Ultrasound guided transrectal core biopsies of the palpably abnormal prostate. J Urol. 1989 Jul;142(1):66–70. doi: 10.1016/s0022-5347(17)38663-9. [DOI] [PubMed] [Google Scholar]
  63. Hosking D. H., Paraskevas M., Hellsten O. R., Ramsey E. W. The cytological diagnosis of prostatic carcinoma by transrectal fine needle aspiration. J Urol. 1983 May;129(5):998–1000. doi: 10.1016/s0022-5347(17)52507-0. [DOI] [PubMed] [Google Scholar]
  64. Huber P. R., Schnell Y., Hering F., Rutishauser G. Prostate specific antigen. Experimental and clinical observations. Scand J Urol Nephrol Suppl. 1987;104:33–39. [PubMed] [Google Scholar]
  65. Hudson M. A., Bahnson R. R., Catalona W. J. Clinical use of prostate specific antigen in patients with prostate cancer. J Urol. 1989 Oct;142(4):1011–1017. doi: 10.1016/s0022-5347(17)38972-3. [DOI] [PubMed] [Google Scholar]
  66. Iversen P., Bak M., Juul N., Laursen F., von der Maase H., Nielsen L., Rasmussen F., Torp-Pedersen S., Holm H. H. Ultrasonically guided 125iodine seed implantation with external radiation in management of localized prostatic carcinoma. Urology. 1989 Oct;34(4):181–186. doi: 10.1016/0090-4295(89)90368-3. [DOI] [PubMed] [Google Scholar]
  67. Jewett H. J. Radical perineal prostatectomy for palpable, clinically localized, non-obstructive cancer: experience at the Johns Hopkins Hospital 1909-1963. J Urol. 1980 Oct;124(4):492–494. doi: 10.1016/s0022-5347(17)55509-3. [DOI] [PubMed] [Google Scholar]
  68. Kabalin J. N., Hodge K. K., McNeal J. E., Freiha F. S., Stamey T. A. Identification of residual cancer in the prostate following radiation therapy: role of transrectal ultrasound guided biopsy and prostate specific antigen. J Urol. 1989 Aug;142(2 Pt 1):326–331. doi: 10.1016/s0022-5347(17)38746-3. [DOI] [PubMed] [Google Scholar]
  69. Kadow C., Gingell J. C., Penry J. B. Prostatic ultrasonography: a useful technique? Br J Urol. 1985 Aug;57(4):440–443. doi: 10.1111/j.1464-410x.1985.tb06306.x. [DOI] [PubMed] [Google Scholar]
  70. Kahn T., Bürrig K., Schmitz-Dräger B., Lewin J. S., Fürst G., Mödder U. Prostatic carcinoma and benign prostatic hyperplasia: MR imaging with histopathologic correlation. Radiology. 1989 Dec;173(3):847–851. doi: 10.1148/radiology.173.3.2479050. [DOI] [PubMed] [Google Scholar]
  71. Kaplan L. A., Chen I. W., Sperling M., Bracken B., Stein E. A. Clinical utility of serum prostatic acid phosphatase measurements for detection (screening), diagnosis, and therapeutic monitoring of prostatic carcinoma; assessment of monoclonal and polyclonal enzymes and radioimmunoassays. Am J Clin Pathol. 1985 Sep;84(3):334–339. doi: 10.1093/ajcp/84.3.334. [DOI] [PubMed] [Google Scholar]
  72. Kenny G. M., Hutchinson W. B. Transrectal ultrasound study of prostate. Urology. 1988 Nov;32(5):401–402. doi: 10.1016/0090-4295(88)90409-8. [DOI] [PubMed] [Google Scholar]
  73. Krieger J. N., Krall J. M., Laramore G. E., Russell K. J., Thomas F. S., Maor M. H., Hendrickson F. R., Griffin T. W. Fast neutron radiotherapy for locally advanced prostate cancer. Update of a past trial and future research directions. Urology. 1989 Jul;34(1):1–9. doi: 10.1016/0090-4295(89)90146-5. [DOI] [PubMed] [Google Scholar]
  74. Kumar P. P., Good R. R., Bartone F. F. Iodine 125 interstitial irradiation for localized prostate cancer. J Natl Med Assoc. 1990 Mar;82(3):181–193. [PMC free article] [PubMed] [Google Scholar]
  75. Labrie F., Dupont A., Cusan L., Giguere M., Bergeron N., Borsanyi J. P., Lacourciere Y., Belanger A., Emond J., Monfette G. Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in previously untreated patients with clinical stage D2 prostate cancer: today's therapy of choice. J Steroid Biochem. 1988;30(1-6):107–117. doi: 10.1016/0022-4731(88)90083-0. [DOI] [PubMed] [Google Scholar]
  76. Labrie F., Dupont A., Cusan L., Manhès G., Bergeron N., Lacourcière Y., Pineault S., Bélanger A., Monfette G., Emond J. Combination therapy with castration and flutamide: today's treatment of choice for prostate cancer. J Steroid Biochem. 1989 Oct;33(4B):817–821. doi: 10.1016/0022-4731(89)90499-8. [DOI] [PubMed] [Google Scholar]
  77. Lange P. H., Brawer M. K. Serum prostate-specific antigen: its use in diagnosis and management of prostate cancer. Urology. 1989 Jun;33(6 Suppl):13–17. [PubMed] [Google Scholar]
  78. Lange P. H. Controversies in management of apparently localized carcinoma of prostate. Urology. 1989 Oct;34(4 Suppl):13–56. doi: 10.1016/0090-4295(89)90229-x. [DOI] [PubMed] [Google Scholar]
  79. Lange P. H., Ercole C. J., Lightner D. J., Fraley E. E., Vessella R. The value of serum prostate specific antigen determinations before and after radical prostatectomy. J Urol. 1989 Apr;141(4):873–879. doi: 10.1016/s0022-5347(17)41037-8. [DOI] [PubMed] [Google Scholar]
  80. Leach G. E., Cooper J. F., Kagan A. R., Snyder R., Forsythe A. Radiotherapy for prostatic carcinoma: post-irradiation prostatic biopsy and recurrence patterns with long-term followup. J Urol. 1982 Sep;128(3):505–509. doi: 10.1016/s0022-5347(17)53019-0. [DOI] [PubMed] [Google Scholar]
  81. Lee F., Littrup P. J., Torp-Pedersen S. T., Mettlin C., McHugh T. A., Gray J. M., Kumasaka G. H., McLeary R. D. Prostate cancer: comparison of transrectal US and digital rectal examination for screening. Radiology. 1988 Aug;168(2):389–394. doi: 10.1148/radiology.168.2.3293108. [DOI] [PubMed] [Google Scholar]
  82. Lee F., Torp-Pedersen S. T., Carroll J. T., Siders D. B., Christensen-Day C., Mitchell A. E. Use of transrectal ultrasound and prostate-specific antigen in diagnosis of prostatic intraepithelial neoplasia. Urology. 1989 Dec;34(6 Suppl):4–8. [PubMed] [Google Scholar]
  83. Lee F., Torp-Pedersen S. T., Siders D. B. The role of transrectal ultrasound in the early detection of prostate cancer. CA Cancer J Clin. 1989 Nov-Dec;39(6):337–360. doi: 10.3322/canjclin.39.6.337. [DOI] [PubMed] [Google Scholar]
  84. Lee F., Torp-Pedersen S., Littrup P. J., McLeary R. D., McHugh T. A., Smid A. P., Stella P. J., Borlaza G. S. Hypoechoic lesions of the prostate: clinical relevance of tumor size, digital rectal examination, and prostate-specific antigen. Radiology. 1989 Jan;170(1 Pt 1):29–32. doi: 10.1148/radiology.170.1.2462262. [DOI] [PubMed] [Google Scholar]
  85. Lee F. Transrectal ultrasound in the diagnosis, staging, guided needle biopsy, and screening for prostate cancer. Prog Clin Biol Res. 1987;237:73–109. [PubMed] [Google Scholar]
  86. Leitenberger A., Altwein J. E. Efficacy and discriminative ability of prostate-specific antigen as a tumor marker. Eur Urol. 1990;17(1):12–16. doi: 10.1159/000463990. [DOI] [PubMed] [Google Scholar]
  87. Lepor H., Walsh P. C. The role of radical prostatectomy in the management of stage B adenocarcinoma of the prostate. Prog Clin Biol Res. 1987;243B:343–356. [PubMed] [Google Scholar]
  88. Leroy M., Teillac P., Rain J. D., Saccavini J. C., Le Duc A., Najean Y. Radioimmunodetection of lymph node invasion in prostatic cancer. The use of iodine 123 (123I)-labeled monoclonal anti-prostatic acid phosphatase (PAP) 227 A F(ab')2 antibody fragments in vivo. Cancer. 1989 Jul 1;64(1):1–5. doi: 10.1002/1097-0142(19890701)64:1<1::aid-cncr2820640102>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  89. Lewenhaupt A., Ekman P., Eneroth P., Nilsson B. Tumour markers as prognostic aids in prostatic carcinoma. Br J Urol. 1990 Aug;66(2):182–187. doi: 10.1111/j.1464-410x.1990.tb14900.x. [DOI] [PubMed] [Google Scholar]
  90. Lightner D. J., Lange P. H., Reddy P. K., Moore L. Prostate specific antigen and local recurrence after radical prostatectomy. J Urol. 1990 Oct;144(4):921–926. doi: 10.1016/s0022-5347(17)39623-4. [DOI] [PubMed] [Google Scholar]
  91. Lê Thi Huong D. u., Wechsler B., Godeau P. Recueil épidémiologique des grossesses lupiques. Ann Med Interne (Paris) 1990;141(3):239–243. [PubMed] [Google Scholar]
  92. Madsen P. O., Graversen P. H., Gasser T. C., Corle D. K. Treatment of localized prostatic cancer. Radical prostatectomy versus placebo. A 15-year follow-up. Scand J Urol Nephrol Suppl. 1988;110:95–100. [PubMed] [Google Scholar]
  93. Mameghan H., Fisher R., Mameghan J., Watt W. H., Tynan A. Bowel complications after radiotherapy for carcinoma of the prostate: the volume effect. Int J Radiat Oncol Biol Phys. 1990 Feb;18(2):315–320. doi: 10.1016/0360-3016(90)90095-2. [DOI] [PubMed] [Google Scholar]
  94. Markham C. W. Prostatic intraepithelial neoplasia: detection and correlation with invasive cancer in fine-needle biopsy. Urology. 1989 Dec;34(6 Suppl):57–61. [PubMed] [Google Scholar]
  95. McClennan B. L. Transrectal US of the prostate: is the technology leading the science? Radiology. 1988 Aug;168(2):571–575. doi: 10.1148/radiology.168.2.3293115. [DOI] [PubMed] [Google Scholar]
  96. McClinton S., Moffat L. E., Ludbrook A. The cost of bilateral orchiectomy as a treatment for prostatic carcinoma. Br J Urol. 1989 Mar;63(3):309–312. doi: 10.1111/j.1464-410x.1989.tb05195.x. [DOI] [PubMed] [Google Scholar]
  97. McDowell G. C., 2nd, Johnson J. W., Tenney D. M., Johnson D. E. Pelvic lymphadenectomy for staging clinically localized prostate cancer. Indications, complications, and results in 217 cases. Urology. 1990 Jun;35(6):476–482. doi: 10.1016/0090-4295(90)80098-8. [DOI] [PubMed] [Google Scholar]
  98. McNeal J. E., Bostwick D. G., Kindrachuk R. A., Redwine E. A., Freiha F. S., Stamey T. A. Patterns of progression in prostate cancer. Lancet. 1986 Jan 11;1(8472):60–63. doi: 10.1016/s0140-6736(86)90715-4. [DOI] [PubMed] [Google Scholar]
  99. McNeal J. E., Price H. M., Redwine E. A., Freiha F. S., Stamey T. A. Stage A versus stage B adenocarcinoma of the prostate: morphological comparison and biological significance. J Urol. 1988 Jan;139(1):61–65. doi: 10.1016/s0022-5347(17)42293-2. [DOI] [PubMed] [Google Scholar]
  100. Meacham R. B., Scardino P. T., Hoffman G. S., Easley J. D., Wilbanks J. H., Carlton C. E., Jr The risk of distant metastases after transurethral resection of the prostate versus needle biopsy in patients with localized prostate cancer. J Urol. 1989 Aug;142(2 Pt 1):320–325. doi: 10.1016/s0022-5347(17)38745-1. [DOI] [PubMed] [Google Scholar]
  101. Mettlin C., Natarajan N. End results for urologic cancers. Trends and interhospital differences. Cancer. 1987 Aug 1;60(3 Suppl):474–479. doi: 10.1002/1097-0142(19870801)60:3+<474::aid-cncr2820601508>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  102. Mizutani A. R., Parker J., Katz J., Schmidt J. Visual disturbances, serum glycine levels and transurethral resection of the prostate. J Urol. 1990 Sep;144(3):697–699. doi: 10.1016/s0022-5347(17)39558-7. [DOI] [PubMed] [Google Scholar]
  103. Montie J. E., Wood D. P., Jr, Pontes J. E., Boyett J. M., Levin H. S. Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer. Cancer. 1989 Jan 15;63(2):381–385. doi: 10.1002/1097-0142(19890115)63:2<381::aid-cncr2820630230>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  104. Morse R. M., Resnick M. I. Detection of clinically occult prostate cancer. Urol Clin North Am. 1990 Aug;17(3):567–574. [PubMed] [Google Scholar]
  105. Morton J. D., Peschel R. E. Iodine-125 implants versus external beam therapy for stages A2, B, and C prostate cancer. Int J Radiat Oncol Biol Phys. 1988 Jun;14(6):1153–1157. doi: 10.1016/0360-3016(88)90392-6. [DOI] [PubMed] [Google Scholar]
  106. Mueller E. J. Cancer of the prostate. Do yearly digital rectal examinations save lives? Postgrad Med. 1989 Nov 15;86(7):115–119. doi: 10.1080/00325481.1989.11700777. [DOI] [PubMed] [Google Scholar]
  107. Murphy G. P., Natarajan N., Pontes J. E., Schmitz R. L., Smart C. R., Schmidt J. D., Mettlin C. The national survey of prostate cancer in the United States by the American College of Surgeons. J Urol. 1982 May;127(5):928–934. doi: 10.1016/s0022-5347(17)54135-x. [DOI] [PubMed] [Google Scholar]
  108. Murphy G. P. Screening for prostatic carcinoma--useful or not? Prog Clin Biol Res. 1988;269:131–145. [PubMed] [Google Scholar]
  109. Nesbitt J. A., Drago J. R., Badalament R. A. Transrectal ultrasonography. Early experience with use as prostate cancer detection tool. Urology. 1989 Sep;34(3):120–122. doi: 10.1016/0090-4295(89)90243-4. [DOI] [PubMed] [Google Scholar]
  110. Newling D. W., Hall R. R., Powell P. H. Deferred treatment in prostatic cancer. Lancet. 1986 Aug 2;2(8501):278–279. doi: 10.1016/s0140-6736(86)92090-8. [DOI] [PubMed] [Google Scholar]
  111. Noguchi K., Moriyama M., Miura T., Kinoshita Y., Kubota Y., Hosaka M. [Usefulness of fine needle aspiration cytology in the diagnosis of prostatic carcinoma]. Hinyokika Kiyo. 1989 Mar;35(3):399–401. [PubMed] [Google Scholar]
  112. Oesterling J. E., Chan D. W., Epstein J. I., Kimball A. W., Jr, Bruzek D. J., Rock R. C., Brendler C. B., Walsh P. C. Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J Urol. 1988 Apr;139(4):766–772. doi: 10.1016/s0022-5347(17)42630-9. [DOI] [PubMed] [Google Scholar]
  113. Palken M., Cobb O. E., Warren B. H., Hoak D. C. Prostate cancer: correlation of digital rectal examination, transrectal ultrasound and prostate specific antigen levels with tumor volumes in radical prostatectomy specimens. J Urol. 1990 Jun;143(6):1155–1162. doi: 10.1016/s0022-5347(17)40213-8. [DOI] [PubMed] [Google Scholar]
  114. Pantelides M. L., Whitehurst C., Moore J. V., King T. A., Blacklock N. J. Photodynamic therapy for localised prostatic cancer: light penetration in the human prostate gland. J Urol. 1990 Feb;143(2):398–401. doi: 10.1016/s0022-5347(17)39973-1. [DOI] [PubMed] [Google Scholar]
  115. Paulson D. F., Hodge G. B., Jr, Hinshaw W. Radiation therapy versus delayed androgen deprivation for stage C carcinoma of the prostate. J Urol. 1984 May;131(5):901–902. doi: 10.1016/s0022-5347(17)50704-1. [DOI] [PubMed] [Google Scholar]
  116. Paulson D. F., Lin G. H., Hinshaw W., Stephani S. Radical surgery versus radiotherapy for adenocarcinoma of the prostate. J Urol. 1982 Sep;128(3):502–504. doi: 10.1016/s0022-5347(17)53016-5. [DOI] [PubMed] [Google Scholar]
  117. Paulson D. F., Piserchia P. V., Gardner W. Predictors of lymphatic spread in prostatic adenocarcinoma: uro-oncology research group study. J Urol. 1980 May;123(5):697–699. doi: 10.1016/s0022-5347(17)56095-4. [DOI] [PubMed] [Google Scholar]
  118. Pavone-Macaluso M., Pavone C., Serretta V., Daricello G. Antiandrogens alone or in combination for treatment of prostate cancer: the European experience. Urology. 1989 Oct;34(4 Suppl):27–56. doi: 10.1016/0090-4295(89)90232-x. [DOI] [PubMed] [Google Scholar]
  119. Pedersen K. V., Carlsson P., Varenhorst E., Löfman O., Berglund K. Screening for carcinoma of the prostate by digital rectal examination in a randomly selected population. BMJ. 1990 Apr 21;300(6731):1041–1044. doi: 10.1136/bmj.300.6731.1041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Peeling W. B. Phase III studies to compare goserelin (Zoladex) with orchiectomy and with diethylstilbestrol in treatment of prostatic carcinoma. Urology. 1989 May;33(5 Suppl):45–52. doi: 10.1016/0090-4295(89)90106-4. [DOI] [PubMed] [Google Scholar]
  121. Perez C. A., Pilepich M. V., Garcia D., Simpson J. R., Zivnuska F., Hederman M. A. Definitive radiation therapy in carcinoma of the prostate localized to the pelvis: experience at the Mallinckrodt Institute of Radiology. NCI Monogr. 1988;(7):85–94. [PubMed] [Google Scholar]
  122. Perrapato S. D., Carothers G. G., Maatman T. J., Soechtig C. E. Comparing clinical staging plus transrectal ultrasound with surgical-pathologic staging of prostate cancer. Urology. 1989 Feb;33(2):103–105. doi: 10.1016/0090-4295(89)90004-6. [DOI] [PubMed] [Google Scholar]
  123. Pilepich M. V., Krall J. M., John M. J., Rubin P., Porter A. T., Marcial V. A., Martz K. L. Hormonal cytoreduction in locally advanced carcinoma of the prostate treated with definitive radiotherapy: preliminary results of RTOG 83-07. Int J Radiat Oncol Biol Phys. 1989 Mar;16(3):813–817. doi: 10.1016/0360-3016(89)90500-2. [DOI] [PubMed] [Google Scholar]
  124. Pontes J. E., Eisenkraft S., Watanabe H., Ohe H., Saitoh M., Murphy G. P. Preoperative evaluation of localized prostatic carcinoma by transrectal ultrasonography. J Urol. 1985 Aug;134(2):289–291. doi: 10.1016/s0022-5347(17)47127-8. [DOI] [PubMed] [Google Scholar]
  125. Powell C. S., Fielding A. M., Rosser K., Ames A. C., Vaughton K. C. Prostate specific antigen--a screening test for prostatic cancer? Br J Urol. 1989 Nov;64(5):504–506. doi: 10.1111/j.1464-410x.1989.tb05287.x. [DOI] [PubMed] [Google Scholar]
  126. Rainwater L. M., Morgan W. R., Klee G. G., Zincke H. Prostate-specific antigen testing in untreated and treated prostatic adenocarcinoma. Mayo Clin Proc. 1990 Aug;65(8):1118–1126. doi: 10.1016/s0025-6196(12)62725-6. [DOI] [PubMed] [Google Scholar]
  127. Rainwater L. M., Segura J. W. Technical consideration in radical retropubic prostatectomy: blood loss after ligation of dorsal venous complex. J Urol. 1990 Jun;143(6):1163–1165. doi: 10.1016/s0022-5347(17)40215-1. [DOI] [PubMed] [Google Scholar]
  128. Rannikko S., Salo J. O. Radical prostatectomy as treatment of localized prostatic cancer. Early results, with special focus on transrectal ultrasound for local staging. Scand J Urol Nephrol. 1990;24(2):103–107. doi: 10.3109/00365599009180372. [DOI] [PubMed] [Google Scholar]
  129. Resnick M. I. Background for screening--epidemiology and cost effectiveness. Prog Clin Biol Res. 1988;269:111–122. [PubMed] [Google Scholar]
  130. Resnick M. I., Kursh E. D., Bryan P. J. Magnetic resonance imaging of the prostate. Prog Clin Biol Res. 1987;243B:89–96. [PubMed] [Google Scholar]
  131. Rifkin M. D., Choi H. Implications of small, peripheral hypoechoic lesions in endorectal US of the prostate. Radiology. 1988 Mar;166(3):619–622. doi: 10.1148/radiology.166.3.3277237. [DOI] [PubMed] [Google Scholar]
  132. Rifkin M. D., Friedland G. W., Shortliffe L. Prostatic evaluation by transrectal endosonography: detection of carcinoma. Radiology. 1986 Jan;158(1):85–90. doi: 10.1148/radiology.158.1.3510030. [DOI] [PubMed] [Google Scholar]
  133. Rock R. C., Chan D. W., Bruzek D., Waldron C., Oesterling J., Walsh P. Evaluation of a monoclonal immunoradiometric assay for prostate-specific antigen. Clin Chem. 1987 Dec;33(12):2257–2261. [PubMed] [Google Scholar]
  134. Roy C. R., 2nd, Horne D., Raife M., Pienkos E. Incidental carcinoma of prostate, Long-term follow-up. Urology. 1990 Sep;36(3):210–213. doi: 10.1016/0090-4295(90)80256-m. [DOI] [PubMed] [Google Scholar]
  135. Sagerman R. H., Chun H. C., King G. A., Chung C. T., Dalal P. S. External beam radiotherapy for carcinoma of the prostate. Cancer. 1989 Jun 15;63(12):2468–2474. doi: 10.1002/1097-0142(19890615)63:12<2468::aid-cncr2820631218>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  136. Salo J. O., Rannikko S., Haapiainen R. Serum acid phosphatase in patients with localised prostatic cancer, benign prostatic hyperplasia or normal prostates. Br J Urol. 1990 Aug;66(2):188–192. doi: 10.1111/j.1464-410x.1990.tb14901.x. [DOI] [PubMed] [Google Scholar]
  137. Samdal F., Brevik B. Laser combined with TURP in the treatment of localized prostatic cancer. Scand J Urol Nephrol. 1990;24(3):175–177. doi: 10.3109/00365599009180854. [DOI] [PubMed] [Google Scholar]
  138. Scardino P. T. Early detection of prostate cancer. Urol Clin North Am. 1989 Nov;16(4):635–655. [PubMed] [Google Scholar]
  139. Scardino P. T., Shinohara K., Wheeler T. M., Carter S. S. Staging of prostate cancer. Value of ultrasonography. Urol Clin North Am. 1989 Nov;16(4):713–734. [PubMed] [Google Scholar]
  140. Schellhammer P. F., Whitmore R. B., 3rd, Kuban D. A., el-Mahdi A. M., Ladaga L. A. Morbidity and mortality of local failure after definitive therapy for prostate cancer. J Urol. 1989 Mar;141(3):567–571. doi: 10.1016/s0022-5347(17)40896-2. [DOI] [PubMed] [Google Scholar]
  141. Schroeder F. H. Treatment of localised prostatic carcinoma. Horm Res. 1989;32 (Suppl 1):44–46. doi: 10.1159/000181308. [DOI] [PubMed] [Google Scholar]
  142. Seamonds B., Yang N., Anderson K., Whitaker B., Shaw L. M., Bollinger J. R. Evaluation of prostate-specific antigen and prostatic acid phosphatase as prostate cancer markers. Urology. 1986 Dec;28(6):472–479. doi: 10.1016/0090-4295(86)90146-9. [DOI] [PubMed] [Google Scholar]
  143. Shinohara K., Scardino P. T., Carter S. S., Wheeler T. M. Pathologic basis of the sonographic appearance of the normal and malignant prostate. Urol Clin North Am. 1989 Nov;16(4):675–691. [PubMed] [Google Scholar]
  144. Shinohara K., Wheeler T. M., Scardino P. T. The appearance of prostate cancer on transrectal ultrasonography: correlation of imaging and pathological examinations. J Urol. 1989 Jul;142(1):76–82. doi: 10.1016/s0022-5347(17)38666-4. [DOI] [PubMed] [Google Scholar]
  145. Smit W. G., Helle P. A., van Putten W. L., Wijnmaalen A. J., Seldenrath J. J., van der Werf-Messing B. H. Late radiation damage in prostate cancer patients treated by high dose external radiotherapy in relation to rectal dose. Int J Radiat Oncol Biol Phys. 1990 Jan;18(1):23–29. doi: 10.1016/0360-3016(90)90262-i. [DOI] [PubMed] [Google Scholar]
  146. Smith J. A., Jr Patient selection for radical prostatectomy. Urology. 1989 May;33(5 Suppl):17–20. doi: 10.1016/0090-4295(89)90101-5. [DOI] [PubMed] [Google Scholar]
  147. Soloway M. Treatment of early prostate cancer. Horm Res. 1989;32 (Suppl 1):59–61. doi: 10.1159/000181312. [DOI] [PubMed] [Google Scholar]
  148. Spirnak J. P., Resnick M. I. Clinical staging of prostatic cancer: new modalities. Urol Clin North Am. 1984 May;11(2):221–235. [PubMed] [Google Scholar]
  149. Stamey T. A., Kabalin J. N., McNeal J. E., Johnstone I. M., Freiha F., Redwine E. A., Yang N. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients. J Urol. 1989 May;141(5):1076–1083. doi: 10.1016/s0022-5347(17)41175-x. [DOI] [PubMed] [Google Scholar]
  150. Stamey T. A., Kabalin J. N. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. I. Untreated patients. J Urol. 1989 May;141(5):1070–1075. doi: 10.1016/s0022-5347(17)41174-8. [DOI] [PubMed] [Google Scholar]
  151. Stamey T. A., McNeal J. E., Freiha F. S., Redwine E. Morphometric and clinical studies on 68 consecutive radical prostatectomies. J Urol. 1988 Jun;139(6):1235–1241. doi: 10.1016/s0022-5347(17)42876-x. [DOI] [PubMed] [Google Scholar]
  152. Stamey T. A., Villers A. A., McNeal J. E., Link P. C., Freiha F. S. Positive surgical margins at radical prostatectomy: importance of the apical dissection. J Urol. 1990 Jun;143(6):1166–1173. doi: 10.1016/s0022-5347(17)40216-3. [DOI] [PubMed] [Google Scholar]
  153. Stamey T. A., Yang N., Hay A. R., McNeal J. E., Freiha F. S., Redwine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med. 1987 Oct 8;317(15):909–916. doi: 10.1056/NEJM198710083171501. [DOI] [PubMed] [Google Scholar]
  154. Teillac P., Bron J., Tobolski F., Cussenot O., Lesourd A., Leroy M., Toubert M. E., Brocheriou C., Laval-Jeantet M., Le Duc A. Dépistage du cancer de la prostate. Etude de 600 cas. Ann Urol (Paris) 1990;24(1):37–41. [PubMed] [Google Scholar]
  155. Teillac P., Leroy M., Rain J. D., Bruneau J., Cheval E., Ketels F., Rabaud B., Saccavini J. C., Najean Y., Le Duc A. Premiers résultats chez l'homme de l'immunolymphoscintigraphie dans le cancer de prostate. Ann Med Interne (Paris) 1989;140(1):20–24. [PubMed] [Google Scholar]
  156. Thompson I. M., Ernst J. J., Gangai M. P., Spence C. R. Adenocarcinoma of the prostate: results of routine urological screening. J Urol. 1984 Oct;132(4):690–692. doi: 10.1016/s0022-5347(17)49828-4. [DOI] [PubMed] [Google Scholar]
  157. Thompson I. M., Rounder J. B., Teague J. L., Peek M., Spence C. R. Impact of routine screening for adenocarcinoma of the prostate on stage distribution. J Urol. 1987 Mar;137(3):424–426. doi: 10.1016/s0022-5347(17)44055-9. [DOI] [PubMed] [Google Scholar]
  158. Thompson I. M., Zeidman E. J. Extended follow-up of stage A1 carcinoma of prostate. Urology. 1989 Jun;33(6):455–458. doi: 10.1016/0090-4295(89)90128-3. [DOI] [PubMed] [Google Scholar]
  159. Torp-Pedersen S. T., Lee F. Transrectal biopsy of the prostate guided by transrectal ultrasound. Urol Clin North Am. 1989 Nov;16(4):703–712. [PubMed] [Google Scholar]
  160. Torp-Pedersen S., Lee F., Littrup P. J., Siders D. B., Kumasaka G. H., Solomon M. H., McLeary R. D. Transrectal biopsy of the prostate guided with transrectal US: longitudinal and multiplanar scanning. Radiology. 1989 Jan;170(1 Pt 1):23–27. doi: 10.1148/radiology.170.1.2642344. [DOI] [PubMed] [Google Scholar]
  161. Vallancien G., Prapotnich D., Sibert L., Lugagne P. M., Veillon B., Brisset J. M., Andre-Bougaran J. Comparison of the efficacy of digital rectal examination and transrectal ultrasonography in the diagnosis of prostatic cancer. Prog Clin Biol Res. 1989;303:1–9. [PubMed] [Google Scholar]
  162. Vecchioli Scaldazza C., Garritano A., Rossi G., Albini C. Il carcinoma incidentale della prostata. Arch Ital Urol Nefrol Androl. 1989 Mar;61(1):37–42. [PubMed] [Google Scholar]
  163. Vicente J., Chéchile G., Algaba F. The role of repeat transurethral resection in stage A1 carcinoma of the prostate. Eur Urol. 1989;16(5):325–327. doi: 10.1159/000471608. [DOI] [PubMed] [Google Scholar]
  164. Vihko P., Kontturi M., Lukkarinen O., Ervasti J., Vihko R. Screening for carcinoma of the prostate. Rectal examination, and enzymatic and radioimmunologic measurements of serum acid phosphatase compared. Cancer. 1985 Jul 1;56(1):173–177. doi: 10.1002/1097-0142(19850701)56:1<173::aid-cncr2820560127>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  165. Villers A. A., McNeal J. E., Redwine E. A., Freiha F. S., Stamey T. A. Pathogenesis and biological significance of seminal vesicle invasion in prostatic adenocarcinoma. J Urol. 1990 Jun;143(6):1183–1187. doi: 10.1016/s0022-5347(17)40220-5. [DOI] [PubMed] [Google Scholar]
  166. Walsh P. C., Lepor H. The role of radical prostatectomy in the management of prostatic cancer. Cancer. 1987 Aug 1;60(3 Suppl):526–537. doi: 10.1002/1097-0142(19870801)60:3+<526::aid-cncr2820601515>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  167. Watanabe H., Date S., Ohe H., Saitoh M., Tanaka S. A survey of 3,000 examinations by transrectal ultrasonotomography. Prostate. 1980;1(3):271–278. doi: 10.1002/pros.2990010302. [DOI] [PubMed] [Google Scholar]
  168. Watanabe H. Preventive oncology project for prostatic cancer. Prog Clin Biol Res. 1987;237:133–142. [PubMed] [Google Scholar]
  169. Waterhouse R. L., Resnick M. I. The use of transrectal prostatic ultrasonography in the evaluation of patients with prostatic carcinoma. J Urol. 1989 Feb;141(2):233–239. doi: 10.1016/s0022-5347(17)40729-4. [DOI] [PubMed] [Google Scholar]
  170. Whitmore W. F., Jr Natural history and staging of prostate cancer. Urol Clin North Am. 1984 May;11(2):205–220. [PubMed] [Google Scholar]
  171. Wigle D. T., Mao Y., Semenciw R., Morrison H. I. Cancer patterns in Canada. CMAJ. 1986 Feb 1;134(3):231–235. [PMC free article] [PubMed] [Google Scholar]
  172. Woolf S. H., Battista R. N., Anderson G. M., Logan A. G., Wang E. Assessing the clinical effectiveness of preventive maneuvers: analytic principles and systematic methods in reviewing evidence and developing clinical practice recommendations. A report by the Canadian Task Force on the Periodic Health Examination. J Clin Epidemiol. 1990;43(9):891–905. doi: 10.1016/0895-4356(90)90073-x. [DOI] [PubMed] [Google Scholar]
  173. van Dongen J. W., van Steenbrugge G. J., Romijn J. C., Schröder F. H. The cytocidal effect of high energy shock waves on human prostatic tumour cell lines. Eur J Cancer Clin Oncol. 1989 Aug;25(8):1173–1179. doi: 10.1016/0277-5379(89)90411-2. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES